Craniopharyngioma is a common intracranial tumour constituting 6% to 13% of all childhood brain tumours and 1% to 3% of all adult brain tumours, with a stable incidence of approximately 1 to 1.5 cases per 1,000,000 per year.[4][7][12] It is the most common sellar region tumour in childhood, and the most common non-glial intracranial tumour. Although it may present at any age, a bimodal age distribution is reported with a peak between 5 and 14 years of age in children and between 50 and 70 years of age in adults.[4][7][12][13] Craniopharyngioma is found worldwide and has no gender preference.[4] One study has found a higher incidence rate in black people, although any racial disparity will need to be confirmed in further studies.[14]

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer